Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Miossec

Showing results (41-50 of 177) with videos related to

Pageof 18
Sort By:
Annals of the Rheumatic Diseases|July 16, 2002
Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activationG Chevrel, P Garnero, P Miossec
Annals of the Rheumatic Diseases|February 21, 2003
Cerebral calcifications in an elderly lupus patientV Filloux, H Marotte, P Miossec
The Journal of Rheumatology|September 11, 1998
Bacillus Calmette-Guérin induced aseptic arthritis: an experimental model of reactive arthritisN Buchs, G Chevrel, P Miossec
Clinical and Experimental Immunology|August 1, 1988
Interleukin 1 derived from human endothelial cells enhances the binding and chemotactic step of T lymphocyte emigrationP Miossec, D Cavender, M Ziff
Arthritis and Rheumatism|January 7, 1998
Th1/Th2 cytokine balance in arthritisP Miossec, W van den Berg
Annals of the Rheumatic Diseases|February 26, 2005
Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitorsG Chevrel, C Granet, P Miossec
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1986
Production of interleukin 1 by human endothelial cellsP Miossec, D Cavender, M Ziff
Immunology Today|April 1, 1996
Bypassing the antigen to control rheumatoid arthritisP Miossec, P Chomarat, J Dechanet
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokinesM Chabaud, G Page, P Miossec
Arthritis and Rheumatism|February 1, 1987
Inhibitor of interleukin-2 in rheumatoid synovial fluidP Miossec, T Kashiwado, M Ziff
Pageof 18

Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|July 16, 2002
Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activationG Chevrel, P Garnero, P Miossec
Annals of the Rheumatic Diseases|February 21, 2003
Cerebral calcifications in an elderly lupus patientV Filloux, H Marotte, P Miossec
The Journal of Rheumatology|September 11, 1998
Bacillus Calmette-Guérin induced aseptic arthritis: an experimental model of reactive arthritisN Buchs, G Chevrel, P Miossec
Clinical and Experimental Immunology|August 1, 1988
Interleukin 1 derived from human endothelial cells enhances the binding and chemotactic step of T lymphocyte emigrationP Miossec, D Cavender, M Ziff
Arthritis and Rheumatism|January 7, 1998
Th1/Th2 cytokine balance in arthritisP Miossec, W van den Berg
Annals of the Rheumatic Diseases|February 26, 2005
Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitorsG Chevrel, C Granet, P Miossec
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1986
Production of interleukin 1 by human endothelial cellsP Miossec, D Cavender, M Ziff
Immunology Today|April 1, 1996
Bypassing the antigen to control rheumatoid arthritisP Miossec, P Chomarat, J Dechanet
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2001
Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokinesM Chabaud, G Page, P Miossec
Arthritis and Rheumatism|February 1, 1987
Inhibitor of interleukin-2 in rheumatoid synovial fluidP Miossec, T Kashiwado, M Ziff
Pageof 18